TLS News
Telos Corporation
$4.82
+$0.04(+0.84%)
56
Overall
60
Value
58
Tech
50
Quality
Market Cap
$360.23M
Volume
835.09K
52W Range
$3.79 - $8.36
Target Price
$6.29
TLS news: the latest Telos Corporation headlines, press releases and market updates, newest first.
Latest TLS News
- Tiziana Life Sciences Reports Positive Phase 2a INFORM-MS Results for Intranasal ForalumabTipRanks Auto-Generated Newsdesk · Nov 5, 2026
- Telstra Cancels 46.6 Million Shares Through BuybackTipRanks Australian Auto-Generated Newsdesk · Nov 4, 2026
- Analysts Offer Insights on Healthcare Companies: Bristol-Myers Squibb (BMY), Tiziana Life Sciences (TLSA) and Verastem (VSTM)TipRanks Newsroom · Nov 3, 2026
- Tiziana Reports Positive Phase 2a Foralumab Results in Progressive MSTipRanks Auto-Generated Newsdesk · Nov 2, 2026
- Materialise Posts Modest Q3 2026 Growth as Medical Segment Leads, Margins TightenTipRanks Auto-Generated Newsdesk · Oct 29, 2026
- Telstra Details Progress of Ongoing On‑Market Share Buy‑BackTipRanks Australian Auto-Generated Newsdesk · Oct 28, 2026
- Telstra Continues On-Market Share Buy-Back ProgramTipRanks Australian Auto-Generated Newsdesk · Oct 26, 2026
- The Week That Was, The Week Ahead: Macro and Markets, October 25Ran Melamed · Oct 25, 2026
- Telstra Updates Investors on Progress of On‑Market Share Buy‑BackTipRanks Australian Auto-Generated Newsdesk · Oct 23, 2026
- TLSA’s BANYAN Trial: Nasal ALS Therapy Enters the Spotlight for InvestorsTipRanks Clinical-Trials-Auto-Generated Newsdesk · Oct 21, 2026
- Telestrada Management Board Issues Position on Share Tender OfferTipRanks Poland Auto-Generated Newsdesk · Oct 21, 2026
- Positive Report for Telia Company AB (TLSNF) from BarclaysTipRanks Auto-Generated Intelligence Newsdesk · Oct 20, 2026
- Telstra Discloses Change in Director Holly Kramer’s ShareholdingsTipRanks Australian Auto-Generated Newsdesk · Oct 20, 2026
- Macquarie Sticks to Its Hold Rating for Telstra Corporation Limited (TTRAF)TipRanks Auto-Generated Intelligence Newsdesk · Oct 18, 2026
- Tiziana Completes Enrollment in Phase 2 Intranasal Foralumab Trial for Mild Alzheimer’sTipRanks Auto-Generated Newsdesk · Oct 16, 2026
- Materialise Expands Share Buyback, Now Holding 2.8% of Outstanding SharesTipRanks Auto-Generated Newsdesk · Oct 13, 2026
- Telstra investors back board and CEO equity incentives at 2026 AGMTipRanks Australian Auto-Generated Newsdesk · Oct 13, 2026
- Telstra Highlights Board Refresh and Governance Focus at 2026 AGMTipRanks Australian Auto-Generated Newsdesk · Oct 12, 2026
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | TLS | $4.82 | +0.8% | 835.09K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |